Best Practice & Research Clinical Endocrinology & Metabolism
Volume 17, Issue 1 , Pages 1-16, March 2003

Medical choices available for management of menopause

  • Elizabeth Farrell, MBBS, FRANZCOG, FRCOG (Head of Unit)

      Affiliations

    • Corresponding Author InformationAddress for correspondence: 372, Albert Street, East Melbourne 3002, Australia. Tel.: +61-3-9419-4877; Fax: +61-3-9415-1709.

Menopause Unit, Monash Medical Centre, Clayton, Australia

Abstract 

The indications for hormone therapy (HT) have changed markedly since the 1980s; they now include the treatment of menopausal symptoms and the prevention and treatment of osteoporosis in the short term. Long-term therapy is discouraged because of the small increase in risk of breast cancer after 5 years of therapy.

Careful assessment of the midlife woman allows for individualized risk–benefit analysis with the formulation of a specific health management plan.

Lifestyle advice and modification form the cornerstone of management—followed by therapeutic options if appropriate indications exist.

In some industrialized countries alternative therapies are preferred despite little scientific evidence of their efficacy. The choices of hormonal products have increased, with the introduction of new formulations and routes of administration allowing for more optimal treatment of the menopause, especially in the presence of concurrent medical conditions, for example, diabetes, breast cancer or fibroids.

Keywords:  hormone therapy, assessment, management plan, lifestyle issues, alternative therapies, concurrent medical conditions

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(02)00087-8

doi:10.1016/S1521-690X(02)00087-8

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 17, Issue 1 , Pages 1-16, March 2003